Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 76, Issue 12, 2005, Pages 1677-1681

  Van Der Linden, F A H ^a   Kragt, J J ^a   Klein, M ^a   Van Der Ploeg, H M ^a   Polman, C H ^a   Uitdehaag, B M J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DATA ANALYSIS; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS IMPACT SCALE; PRIORITY JOURNAL; PSYCHOMETRY; RELIABILITY; VALIDATION PROCESS;

ADULT; FEMALE; HEALTH STATUS; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; MULTIPLE SCLEROSIS; PROXY; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 28144437871     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2005.065227     Document Type: Article

References (19)

1. Riemsma RP, Forbes CA, Glanville JM, et al. General health status measures for people with cognitive impairment: learning disability and acquired brain injury. Health Technol Assess 2001;5:1-100.
2. Rao SM, Leo GJ, Bernardin L, et al. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991;41:685-91.
3. Janssens AC, van Doom PA, de Boer JB, et al. Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis. Mult Scler 2003;9:397-403.
4. Kenealy PM, Beaumont GJ, Lintern T, et al. Autobiographical memory, depression and quality of life in multiple sclerosis. J Clin Exp Neuropsychol 2000;22:125-31.
5. Hanita M. Self-report measures of patient utility: should we trust them? J Clin Epidemiol 2000;53(5):469-476.
6. Benedict RH, Cox D, Thompson LL, et al. Reliable screening for neuropsychological impairment in multiple sclerosis. Mult Scler 2004;10(6):675-678.
7. Maor Y, Olmer L, Mozes B. The relation between objective and subjective impairment in cognitive function among multiple sclerosis patients-the role of depression. Mult Scler 2001;7:131-5.
8. Goverover Y, Chiaravalloti N, DeLuca J. The relationship between self-awareness of neurobehavioral symptoms, cognitive functioning, and emotional symptoms in multiple sclerosis. Mult Scler 2005;11:203-12.
9. Marrie RA, Miller DM, Chelune GJ, et al. Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis. Mult Scler 2003;9:621-6.
10. Benedict RH, Fishman I, McClellan MM, et al. Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis. Mult Scler 2003;9:393-6.
11. Benedict RH, Munschauer F, Linn R, et al. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Mult Scler 2003;9:95-101.
12. Gold SM, Schulz H, Monch A, et al. Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures. Mult Scler 2003;9:404-10.
13. Hobart JC, Riazi A, Lamping DL, et al. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. Health Technol Assess 2004;8.
14. Hobart JC, Cano S, O'Conner R, et al. Multiple Sclerosis Impact Scale-29 (MSIS-29): measurement stability across eight European countries. Mult Scler 2003;9(suppl 1):23.
15. Norman GR, Stratford P, Regehr G. Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach. J Clin Epidemiol 1997;50:869-79.
16. Juniper EF, Guyatt GH, Willan A, et al. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 1994;47:81-7.
17. Sneeuw KC, Sprangers MA, Aaronson NK. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease. J Clin Epidemiol 2002;55:1130-43.
18. Riazi A, Hobart JC, Lamping DL, et al. Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples. J Neurol Neurosurg Psychiatry 2002;73:701-4.
19. Riazi A, Hobart JC, Lamping DL, et al. Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales. Mult Scler 2003;9:411-19.